(This is Part 5 of The Innovation Ecosystem: MitraClip® series. Part 1 reviewed cardiac anatomy, valve disease, and treatment. Part 2 reviewed the MitraClip system. Part 3 reviewed the company Evalve. Part 4 looked at the safest and efficacy of the MitraClip system.) Abbot Vascular met with the FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee on Mar….
Thomson Reuters released their 2012 State of Innovation report which showed the medical device technology area had the largest growth in patent activity. This underscores the needs to address health issues.
Because it probably doesn’t need to be repeated, it bears worth repeating. Communication is what your audience does.
Is the MitraClip designed to replace mitral valve surgery or is it an option for patients who are not candidates for surgery?